Stay updated on Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.

Latest updates to the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page
- Check3 days agoChange DetectedThe page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a software/version change rather than any change to the clinical trial record.SummaryDifference0.1%

- Check10 days agoChange DetectedA new revision (v3.5.2) dated 2026-04-13 adds Oversight and Study Status to the record history; the previous revision (v3.5.0) dated 2025-10-09 is removed.SummaryDifference0.5%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision v3.5.0 was added and v3.4.3 was removed from the history.SummaryDifference0.1%

- Check46 days agoChange DetectedA new version entry, Revision: v3.4.3, was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check74 days agoChange DetectedA new revision (v3.4.2) was added to the record history, and an earlier revision (v3.4.1) was removed, along with a government funding notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check81 days agoChange DetectedA government funding notice was added and the page revision was updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.